Charts J. Molner

Equities

Delayed Nasdaq Tallinn Other stock markets 04:11:16 2024-06-04 am EDT			5-day change	1st Jan Change
13.1 ^EUR	0.00%		-5.07%	-4.73%

Apr. 30	J. Molner AS Gains US FDA Approval for First Estonian-Developed ANDA - Lidocaine Hydrochloride Topical Solution 4%	CI
Mar. 04	J. Molner AS Enters into an Agreement with the US Centers for Medicaid and Medicare Services	CI

ProRealTime Chart